Literature DB >> 9886596

Factors influencing morbidity in patients undergoing transurethral resection of the prostate.

T Uchida1, M Ohori, S Soh, T Sato, M Iwamura, T Ao, K Koshiba.   

Abstract

OBJECTIVES: Transurethral resection of the prostate (TURP) has become the primary method to relieve bladder outlet obstruction for patients with benign prostatic hyperplasia (BPH). Data from 3861 consecutive patients with BPH who underwent TURP from 1971 to 1996 at our hospital were retrospectively analyzed.
METHODS: The patients were classified into two groups comprising 1930 patients who underwent TURP from 1971 to 1985 (early group) and 1931 patients who underwent TURP from 1985 to 1996 (late group). Risk factors associated with blood transfusions and perioperative complications were analyzed in these patients.
RESULTS: Mortality, morbidity, and blood transfusions were noted in 5 (0.1 %), 516 (13.4%), and 507 (13.1%) patients, respectively. The blood transfusion and morbidity rates decreased over the 25-year period (P <0.001, chi-square test for trends), which was reflected in a decrease in these rates in the late group (6.1% and 9.5%, respectively) compared with those of the early group (20.2% and 17.2%, respectively). Postoperative bleeding and morbidity were closely related to prostatic gland size and operating time. The most significant differences for the risk of a blood transfusion were related to resection time, the amount of tissue resected, age, and the decade (1970s, 1980s, or 1990s) in which the surgery was performed (P <0.0005), whereas resection time was significantly correlated with morbidity (P <0.0005). As risk factors for each complication, the time of surgical resection, the decade of surgery, and the amount of tissue resected directly correlated with the incidence of extravasation and hemostatic procedures (P < or =0.003), whereas the incidence of postoperative epididymitis positively correlated with a preoperative vasectomy and a closed drainage system (P <0.0005).
CONCLUSIONS: Since the 1970s, the rates of blood transfusions and morbidity have decreased for patients undergoing TURP. Advances in techniques, instrumentation, and surgical and perioperative management, including anesthesia, have made TURP a relatively safe procedure, and it remains an effective means for treating patients with BPH.

Entities:  

Mesh:

Year:  1999        PMID: 9886596     DOI: 10.1016/s0090-4295(98)00524-x

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  19 in total

1.  Impact of 120-W 2-μm continuous wave laser vapoenucleation of the prostate on sexual function.

Authors:  Yubin Wang; Jinkai Shao; Yongning Lu; Yongan Lü; Xiaodong Li
Journal:  Lasers Med Sci       Date:  2013-07-05       Impact factor: 3.161

2.  Benign Prostatic Hyperplasia Treatment by Transurethral Enucleation of the Prostate Using a 2-μm Laser.

Authors:  He-Qing Guo; Gao-Biao Zhou; Hong-Ming Liu; Bin Sun; Guang-Xin Pan; Da-Wei Mu; Jing-Ming Yan; Ji-Zhang Xing; Di Li; Quan Hong
Journal:  Indian J Surg       Date:  2015-06-12       Impact factor: 0.656

Review 3.  Prevention and management of TURP-related hemorrhage.

Authors:  Liam E Kavanagh; Gregory S Jack; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2011-08-16       Impact factor: 14.432

Review 4.  Changing therapeutic regimens in benign prostatic hyperplasia. Clinical and economic considerations.

Authors:  H J Stoevelaar; J McDonnell
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

5.  Analysis of the factors causing bladder irritation after transurethral resection of the prostate.

Authors:  Tae Im Kim; Jae Mann Song; Hyun Chul Chung
Journal:  Korean J Urol       Date:  2010-10-21

6.  Transurethral resection of the prostate with a bipolar tissue management system compared to conventional monopolar resectoscope: one-year outcome.

Authors:  Chang-Jun Yoon; Ji-Yoon Kim; Ki-Hak Moon; Hee-Chang Jung; Tong-Choon Park
Journal:  Yonsei Med J       Date:  2006-10-31       Impact factor: 2.759

7.  TRUS versus transabdominal ultrasound as a predictor of enucleated adenoma weight in patients with BPH: a tool for standard preoperative work-up?

Authors:  Konstantinos G Stravodimos; Andreas Petrolekas; Theodoros Kapetanakis; Stavros Vourekas; Georgios Koritsiadis; Ioannis Adamakis; Dionysios Mitropoulos; Constantinos Constantinides
Journal:  Int Urol Nephrol       Date:  2009-04-07       Impact factor: 2.370

8.  Application of two micron laser vaporesection combined with transurethral resection of the prostate in treatment of benign prostatic hyperplasia: analysis of 340 cases.

Authors:  Zhiyong Yao; Bin Sun; Gaobiao Zhou; Yonghong Yang; Lei Zhang; Lanlan Liu; Haibo Sheng; Heqing Guo
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 9.  Reasons to overthrow TURP: bring on Aquablation.

Authors:  Iman Sadri; Adel Arezki; Félix Couture; David-Dan Nguyen; Russell Schwartz; Ahmed S Zakaria; Dean Elterman; Enrique Rijo; Vincent Misrai; Thorsten Bach; Claus G Roehrborn; Kevin C Zorn
Journal:  World J Urol       Date:  2020-08-01       Impact factor: 4.226

Review 10.  Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function.

Authors:  A Hoznek; C C Abbou
Journal:  Curr Urol Rep       Date:  2001-08       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.